Cargando…
Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2
In response to the HIV–AIDS pandemic, great strides have been made in developing molecular methods that accurately quantify nucleic acid products of HIV-1 at different stages of viral replication and to assess HIV-1 sequence diversity and its effect on susceptibility to small molecule inhibitors and...
Autores principales: | McCormick, Kevin D., Mellors, John W., Jacobs, Jana L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752249/ https://www.ncbi.nlm.nih.gov/pubmed/33186228 http://dx.doi.org/10.1097/COH.0000000000000656 |
Ejemplares similares
-
Molecular epidemiology in the HIV and SARS-CoV-2 pandemics
por: Lorenzo-Redondo, Ramon, et al.
Publicado: (2021) -
THE INFLUENCE OF HIV-1 SUBTYPES C, CRF31_BC AND B ON DISEASE PROGRESSION
AND INITIAL VIROLOGIC RESPONSE TO HAART IN A SOUTHERN BRAZILIAN
COHORT
por: Nunes, Cynara Carvalho, et al.
Publicado: (2014) -
DETERMINATION OF VIRAL TROPISM BY GENOTYPING AND PHENOTYPING ASSAYS IN
BRAZILIAN HIV-1-INFECTED PATIENTS
por: Arruda, Liã Bárbara, et al.
Publicado: (2014) -
HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China
por: Leng, Xuebing, et al.
Publicado: (2014) -
A Review of the Virological Efficacy of the 4 World Health Organization–Recommended Tenofovir-Containing Regimens for Initial HIV Therapy
por: Tang, Michele W., et al.
Publicado: (2012)